![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 45/06 | (2006.01) |
A61K 31/194 | (2006.01) | ||
A61K 31/197 | (2006.01) | ||
A61K 31/216 | (2006.01) | ||
A61K 31/41 | (2006.01) | ||
A61K 31/221 | (2006.01) | ||
A61K 31/401 | (2006.01) | ||
A61K 31/225 | (2006.01) | ||
A61P 9/12 | (2006.01) | ||
A61P 9/10 | (2006.01) |
(11) | Number of the document | 3626270 |
(13) | Kind of document | T |
(96) | European patent application number | 19202854.6 |
Date of filing the European patent application | 2014-08-26 | |
(97) | Date of publication of the European application | 2020-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2023-10-11 |
(46) | Date of publication of the claims translation | 2024-01-25 |
(30) | Number | Date | Country code |
PCT/US2013/056680 | 2013-08-26 | WO | |
201461972933 P | 2014-03-31 | US |
(72) |
SHI, Victor Chengwei , US
LEFKOWITZ, Martin , US
RIZKALA, Adel Remond , US
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Širdies ir kraujagyslių ligų gydymas |
TREATMENT OF CARDIOVASCULAR DISEASES |
Payment date | Validity (years) | Amount | |
2025-07-23 | 12 | 289.00 EUR |
2026-08-26 |